{"id":"W2329755771","doi":"10.1097/mib.0000000000000396","title":"Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis","year":2015,"lang":"en","type":"review","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Placebo; Adverse effect; Maintenance therapy; Relative risk; Confidence interval; Randomized controlled trial; Meta-analysis; Crohn's disease; Incidence (geometry); Clinical trial; Gastroenterology; Disease; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003325099,0.0004978811,0.0008886729,0.0002000295,0.00006412737,0.00002860064,0.0002592641,0.0004714639,0.00001026498],"category_scores_gemma":[0.0005345451,0.0004644228,0.0003470687,0.00009796117,0.0002542188,0.00001870261,0.0001724011,0.0001561504,0.000004730345],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001322702,"about_ca_system_score_gemma":0.001284496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004533225,"about_ca_topic_score_gemma":0.00004974628,"domain_scores_codex":[0.9975997,0.0003141136,0.0008218143,0.0006717702,0.000220591,0.0003720415],"domain_scores_gemma":[0.9982491,0.00004608672,0.0005507046,0.0005461728,0.00029315,0.0003147963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004736772,0.0004376413,0.003325494,0.07874719,0.0005729315,0.0005370878,0.0002426965,0.00004006705,0.0001004899,0.001302379,0.01861795,0.8913393],"study_design_scores_gemma":[0.001755242,0.0001488236,0.01885579,0.007209676,0.0004739029,0.00003370369,0.00009786955,0.0000166139,0.00002225431,0.0004076242,0.9702156,0.0007628629],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01868082,0.9770669,0.00002659866,0.000006865885,0.0003008838,0.002350587,0.001300332,0.00002735527,0.0002396217],"genre_scores_gemma":[0.002358162,0.994791,0.0001033646,0.00002308969,0.0004333899,0.0008541102,0.0009614119,0.0001101279,0.0003653905],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9515977,"threshold_uncertainty_score":0.9997808,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02318269652308001,"score_gpt":0.3018034280980947,"score_spread":0.2786207315750147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}